Glaxo and Genmab drop IV version of MS immune drug

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Glaxo and Genmab drop IV version of MS immune drug

Postby MSUK » Thu Sep 16, 2010 11:32 pm

Image

GlaxoSmithKline PLC and Genmab A/S will end the development of an intravenous form of a drug intended to treat autoimmune diseases like lupus and multiple sclerosis, and focus on an injectable version.

The companies said an injectable version of Arzerra (ofatumumab) should be more convenient for patients and have fewer side effects. The drug can also be used to treat rheumatoid arthritis...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2156
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service

cron